Project description
Human small intestine organoids: gut epithelial cells in inflammatory bowel disease
Inflammatory bowel disease (IBD) is characterised by inflammation of the gastrointestinal tract caused by a dysregulated immune response to gut bacterial infection. The mechanism underlying this dysregulation is not clear. However, the role of gut epithelial cells in controlling gut microbes is gaining increasing attention. With the support of the Marie Skłodowska-Curie Actions programme, the Epi-IBD project will establish an in vitro model of IBD based on human small intestine organoids composed of differentiated intestinal cells. The team will use this to study how the intestinal epithelium responds to bacterial infection in the context of IBD, evaluating both a well-known IBD genetic predisposition and novel mechanisms.
Objective
As the first line of defense against intestinal pathogens, gut epithelial cells are an essential part of the immune system. They may play an important role in immune-mediated diseases such as Inflammatory Bowel Disease (IBD). IBD is a group of disorders characterized by chronic inflammation of the gastrointestinal tract. IBD prevalence is high in Western countries (0.3% in 2018) and it is rising in newly industrialized countries.
A prevailing model is that the interplay of two factors may cause IBD. First, a genetic predisposition weakens the gut immune system and causes high susceptibility to bacterial infection. Second, pathogenic bacteria infect the gut and trigger chronic inflammation.
It is still unclear how the gut immune system may fail to repress bacterial infection in IBD. Historically, most studies have been focusing on immune cells of the hematopoietic lineage, such as macrophages and lymphocytes. However, the role of gut epithelial cells in controlling gut microbes is now gaining increasing attention. In this project, I propose to use organoids composed of differentiated intestinal cells to study how the intestinal epithelium responds to bacterial infection in the context of IBD.
I will establish an in vitro model of IBD based on human small intestine organoids. I will infect the organoids with the bacterium Adherent-Invasive Escherichia coli (AIEC) and study how the differentiated intestinal cells respond to AIEC invasion. I will both test the relevance of a well-known IBD genetic predisposition (the mutation 1007fs in Nucleotide-binding oligomerization domain 2 (Nod2)) and explore novel mechanisms underlying the immune response of gut epithelial cells using RNAseq and CRISPR base editing. My project will dissect the molecular mechanisms of IBD. In addition, it will improve our understanding of the immune response of epithelial cells, which are an under-studied component of the immune system.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- natural sciences biological sciences microbiology bacteriology
- natural sciences biological sciences genetics mutation
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
HORIZON.1.2 - Marie Skłodowska-Curie Actions (MSCA)
MAIN PROGRAMME
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) HORIZON-MSCA-2022-PF-01
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
1011 JV AMSTERDAM
Netherlands
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.